Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myron Chang

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|August 27, 2014
Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology groupSarah Alexander, Jacqueline M Kraveka, Sheila Weitzman, et al.
Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.
Leukemia Research|May 2, 2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsyMaxim Norkin, Myron Chang, Qi An, et al.
Leukemia Research|November 18, 2016
Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patientsLeylah Drusbosky, Cindy Medina, Regina Martuscello, et al.
The American Journal of Gastroenterology|March 30, 2016
Impact of Endotracheal Intubation on Interventional Endoscopy Unit Efficiency Metrics at a Tertiary Academic Medical CenterYaseen B Perbtani, Robert J Summerlee, Dennis Yang, et al.
Pediatric Blood & Cancer|April 6, 2011
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology GroupMartin A Champagne, Cecilia H Fu, Myron Chang, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|November 23, 2017
Implementation of a Routine Health Literacy Assessment at an Academic Medical CenterCarrie D Warring, Jacqueline R Pinkney, Elaine D Delvo-Favre, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortLi-Mei Chen, Myron Chang, Yunfeng Dai, et al.
Blood|January 9, 2010
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|August 27, 2014
Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology groupSarah Alexander, Jacqueline M Kraveka, Sheila Weitzman, et al.
Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.
Leukemia Research|May 2, 2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsyMaxim Norkin, Myron Chang, Qi An, et al.
Leukemia Research|November 18, 2016
Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patientsLeylah Drusbosky, Cindy Medina, Regina Martuscello, et al.
The American Journal of Gastroenterology|March 30, 2016
Impact of Endotracheal Intubation on Interventional Endoscopy Unit Efficiency Metrics at a Tertiary Academic Medical CenterYaseen B Perbtani, Robert J Summerlee, Dennis Yang, et al.
Pediatric Blood & Cancer|April 6, 2011
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology GroupMartin A Champagne, Cecilia H Fu, Myron Chang, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|November 23, 2017
Implementation of a Routine Health Literacy Assessment at an Academic Medical CenterCarrie D Warring, Jacqueline R Pinkney, Elaine D Delvo-Favre, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2014
External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohortLi-Mei Chen, Myron Chang, Yunfeng Dai, et al.
Blood|January 9, 2010
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AMLJessica A Pollard, Todd A Alonzo, Robert B Gerbing, et al.
Pageof 7